Email this article to a friend
The potential benefits of low-molecular-weight heparins in cancer patients
-
Correspondence: Francisco Robert pacorobertuab@cs.com
Journal of Hematology & Oncology 2010, 3:3 doi:10.1186/1756-8722-3-3